Actively Recruiting
Open-label Phase 1 Study Evaluating Safety and How the Body Processes Increasing Doses of Ingavirin Forte Capsules in Healthy Adults Aged 18 to 45
Led by Valenta Pharm JSC · Updated on 2025-07-08
36
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting a Phase 1, single-center study to assess the safety, tolerability, and how the body processes different ascending doses of Ingavirin Forte capsules in healthy adult volunteers. This study focuses on understanding the effects of the drug in people without influenza or viral respiratory infection symptoms, aiming to gather important information about the drugs profile when given as single and multiple oral doses. Participants will receive Ingavirin Forte capsules in increasing doses 90 mg combined with either 5 mg, 10 mg, or 20 mg of an additional compound. Each participant takes one capsule under fasting conditions, followed by twice-daily dosing for two days first dose fasting, second dose two hours after a meal, and a final morning dose under fasting on the third day. A wash-out period of 7 to 21 days follows the single-dose phase before the next stage. During the study, participants will be closely monitored through physical exams, vital signs checks, blood and urine tests, and electrocardiograms. The study will measure how the drug is absorbed, reaches peak levels, and is eliminated over time. Safety is evaluated by recording any adverse events, physical complaints, and lab test results throughout screening, dosing, wash-out, and observation periods. The total participation duration varies with each dosing phase and monitoring schedule.
CONDITIONS
Brief Title
Study of the Safety, Tolerability, and Pharmacokinetic Profile of Ascending Doses of Ingavirin Forte, Capsules, Folliwing Single and Subsequent Multiple Oral Administration in Healthy Volunteers
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here